GO:0051033 RNA transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051033 RNA transmembrane transporter activity is a molecular function that enables the transfer of RNA across a membrane.
• The best-characterized RNA transmembrane transporter is SID-1 (systemic RNA interference defective-1), a conserved dsRNA channel that mediates cellular RNA uptake and systemic RNAi.
• RNA transmembrane transport is essential for systemic RNA interference, antiviral defense, and intercellular RNA signaling in animals.
• Dysregulation of RNA transport contributes to viral pathogenesis, cancer, and neurological disorders.
• CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect RNA transporter function and identify new therapeutic targets [1,3].
• High-throughput CRISPR library screening combined with RNA-seq and Ribo-seq can uncover regulators of RNA transmembrane transport [2,5].
Description
RNA transmembrane transporter activity (GO:0051033) is a molecular function that enables the movement of ribonucleic acid (RNA) across a biological membrane. This activity is distinct from nuclear RNA export or cytoplasmic RNA trafficking; it specifically mediates the translocation of RNA molecules from one side of a lipid bilayer to the other. The prototypical example is SID-1 (systemic RNA interference defective-1), a multi-pass transmembrane protein that forms a channel for double-stranded RNA (dsRNA) uptake in Caenorhabditis elegans and mammals. Understanding this activity is critical because RNA transport across membranes underpins systemic RNA interference, cell-to-cell RNA signaling, and antiviral immunity. Moreover, defects in RNA transport are linked to viral infections, cancer progression, and neurodegenerative diseases. Researchers studying RNA transmembrane transporter activity need robust experimental models to determine whether candidate genes are causally involved in RNA uptake, export, or intercellular transfer [1,3]. This article provides a comprehensive overview of the ontology, mechanisms, key genes, disease associations, and cutting-edge research methods for GO:0051033.
RNA transmembrane transporter activity At A Glance
| GO ID | GO:0051033 |
|---|---|
| GO term | RNA transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | None |
| Major function | Enables transfer of RNA across a membrane |
| Representative protein | SID-1 (systemic RNA interference defective-1) |
| Substrate | Double-stranded RNA (dsRNA), small interfering RNA (siRNA) |
| Directionality | Inward or outward across the plasma or endosomal membrane |
| Associated process | Systemic RNA interference, antiviral defense, intercellular RNA signaling |
What Is GO:0051033?
RNA transmembrane transporter activity (GO:0051033) is defined as the molecular function that enables the transfer of RNA, ribonucleic acid, from one side of a membrane to the other. This activity typically involves a transmembrane protein that forms a pore or channel through which RNA molecules pass, often in a sequence-independent manner. It is distinct from RNA binding or RNA helicase activities, as it specifically requires membrane translocation.
Why Is RNA transmembrane transporter activity Important in Cell Biology?
RNA transmembrane transporter activity is crucial for systemic RNA interference, a process in which dsRNA taken up by cells triggers gene silencing throughout an organism. This activity also facilitates intercellular RNA transfer, contributing to antiviral immunity and tissue homeostasis. Dysregulation of RNA transport is implicated in viral pathogenesis, cancer, and neurological disorders. Therefore, understanding the molecular mechanisms and regulation of RNA transmembrane transporters is essential for developing RNA-based therapeutics and diagnostics.
• Enables systemic RNA interference and gene silencing across tissues.
• Mediates cellular uptake of therapeutic RNA, including siRNA and mRNA.
• Plays a role in antiviral defense by importing viral dsRNA to trigger RNAi.
• Contributes to intercellular RNA signaling and tissue homeostasis.
• Dysregulation is linked to cancer progression and metastasis.
• Implicated in neurodegenerative diseases through defective RNA transport.
• Serves as a target for enhancing RNA drug delivery.
• Provides a mechanism for systemic spread of RNA-based signals.
• Potential biomarker for viral susceptibility and RNAi efficiency.
• Enables functional genomics screens using RNAi.
What Happens During RNA transmembrane transporter activity?
Substrate Recognition and Binding
In simple terms: The transporter first grabs the RNA molecule.
RNA transmembrane transporters, such as SID-1, recognize and bind double-stranded RNA (dsRNA) in the extracellular space or endosomal lumen. Binding is thought to be sequence-independent and involves electrostatic interactions with the RNA backbone. This step is essential for subsequent translocation and can be regulated by accessory proteins.
Membrane Translocation
In simple terms: The RNA is moved through the membrane channel.
Upon binding, the transporter undergoes conformational changes that allow the RNA molecule to pass through a hydrophilic pore spanning the lipid bilayer. Cryo-EM studies of SID-1 reveal a conserved channel architecture with a central cavity that accommodates dsRNA. The translocation process is energy-independent and driven by concentration gradients.
Release and Downstream Signaling
In simple terms: The RNA is released inside the cell to do its job.
After translocation, the RNA is released into the cytoplasm, where it can be processed by Dicer and incorporated into the RNA-induced silencing complex (RISC) to mediate gene silencing. This release step is critical for systemic RNAi and intercellular RNA signaling.
Regulation by Cellular Cues
In simple terms: The cell can adjust how much RNA it takes up.
RNA transport activity is regulated by developmental cues, viral infection, and stress signals. For example, interferon signaling can upregulate RNA transporter expression to enhance antiviral RNAi. Post-translational modifications, such as phosphorylation, may also modulate transporter activity.
Key Genes Involved in GO:0051033 RNA transmembrane transporter activity
The following genes encode proteins with RNA transmembrane transporter activity or are directly involved in its regulation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SID-1 | Primary dsRNA transmembrane channel | Mediates systemic RNAi; knockout abolishes RNAi spreading |
| SID-2 | Accessory protein for dsRNA uptake | Required for environmental RNAi in C. elegans |
| SID-3 | Kinase involved in RNAi transport | Regulates SID-1 function |
| SID-5 | Endosomal protein for RNA transport | Facilitates dsRNA import |
| RSD-3 | Endosomal RNA transporter | Mediates dsRNA uptake in C. elegans |
| RSD-2 | RNA transport factor | Required for systemic RNAi |
| RSD-6 | RNA transport factor | Required for systemic RNAi |
| DCR-1 | Dicer ribonuclease | Processes transported dsRNA into siRNA |
| RDE-1 | Argonaute protein | Binds siRNA for gene silencing |
| RDE-4 | dsRNA-binding protein | Facilitates dsRNA processing |
| MUT-7 | Exonuclease | Amplifies RNAi signal |
| EGO-1 | RNA-dependent RNA polymerase | Amplifies systemic RNAi |
| HRDE-1 | Argonaute protein | Transmits RNAi to germline |
| SID-1 (human) | Human homolog of SID-1 | Mediates dsRNA uptake in mammalian cells |
| SIDT1 | Human SID-1 transmembrane family member 1 | Lipid hydrolytic activity; RNA transport |
| SIDT2 | Human SID-1 transmembrane family member 2 | RNA transport and innate immunity |
| CLIC1 | Chloride intracellular channel 1 | Potential RNA transporter in cancer |
| ATP1A1 | Sodium/potassium-transporting ATPase | Indirect role in RNA transport |
How Is RNA transmembrane transporter activity Regulated?
RNA transmembrane transporter activity is regulated at multiple levels. Transcriptional regulation of SID-1 and its homologs occurs in response to developmental signals and viral infection. Post-translational modifications, including phosphorylation and ubiquitination, modulate transporter stability and activity. Additionally, accessory proteins such as SID-2 and SID-5 are required for efficient RNA transport. In mammals, interferon signaling upregulates SIDT1 and SIDT2 expression, enhancing antiviral RNAi. Dysregulation of these regulatory mechanisms can lead to impaired RNAi and increased susceptibility to viral infections.
RNA transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SIDT1 | Cancer progression | Knockout in cancer cell lines |
| SIDT2 | Viral infection | Overexpression in HEK293 cells |
| SID-1 | Systemic RNAi deficiency | C. elegans knockout |
| CFTR | Cystic fibrosis | Point mutation knock-in mice |
| CLIC1 | Cancer metastasis | Knockdown in breast cancer cells |
Viral Infections
RNA transmembrane transporters are exploited by viruses to deliver viral RNA into cells, triggering antiviral RNAi. However, some viruses evade RNAi by blocking transporter activity. Understanding these interactions can inform antiviral therapies.
Cancer
Altered RNA transport is observed in cancer cells, where it can promote oncogenic signaling and drug resistance. For example, overexpression of SIDT1 is associated with poor prognosis in certain cancers.
Neurodegenerative Disorders
Defective RNA transport across membranes contributes to neuronal dysfunction and degeneration. Mutations in RNA transporter genes have been linked to amyotrophic lateral sclerosis (ALS) and Alzheimer's disease.
Cystic Fibrosis
Although primarily a chloride channel disease, cystic fibrosis transmembrane conductance regulator (CFTR) mutations can affect RNA transport indirectly by altering membrane composition.
From RNA transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SID-1 mediate dsRNA uptake? | SID-1 knockout C. elegans |
| What is the structure of human SIDT1? | Cryo-EM of purified SIDT1 |
| Can SIDT2 enhance RNAi? | SIDT2 overexpression in mammalian cells |
| Does a point mutation in SID-1 abolish transport? | CRISPR point mutation knock-in |
| Which genes regulate RNA transport? | Genome-wide CRISPR library screen |
| Does RNA transport affect drug resistance? | Knockout in cancer cell lines |
How to Study the RNA transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identify pathways affected by RNA transport |
| Ribo-seq | Translation efficiency | Measure protein synthesis after RNA uptake |
| Cryo-EM | Protein structure | Determine transporter architecture |
| CRISPR screen | Gene essentiality | Discover regulators of RNA transport |
| Fluorescence microscopy | RNA localization | Track RNA uptake in live cells |
| Patch clamp | Ion channel activity | Measure transporter conductance |
| Mass spectrometry | Protein interactions | Identify transporter binding partners |
RNA Sequencing (RNA-seq)
RNA-seq measures global gene expression changes upon modulation of RNA transporter activity, revealing downstream pathways and off-target effects.
Ribosome Profiling (Ribo-seq)
Ribo-seq captures translating ribosomes, providing a snapshot of protein synthesis affected by RNA transport.
Cryo-Electron Microscopy (Cryo-EM)
Cryo-EM resolves the three-dimensional structure of RNA transporters, revealing conformational changes during translocation.
CRISPR Library Screening
Genome-wide CRISPR knockout or activation screens identify genes that regulate RNA transmembrane transport and systemic RNAi.
How CRISPR Can Be Used to Study GO:0051033 RNA transmembrane transporter activity
Knockout
CRISPR knockout of SID-1 or SIDT1/2 abolishes RNA transmembrane transport, providing a clean background to study loss-of-function phenotypes. Knockout cell lines are essential for validating the role of specific transporters in RNAi and viral defense.
Point Mutation
CRISPR point mutation knock-in introduces specific amino acid substitutions in transporter genes to dissect pore structure, substrate specificity, and regulatory phosphorylation sites. This approach is invaluable for modeling human disease-associated mutations.
Knock-in
CRISPR knock-in of epitope tags or fluorescent reporters into endogenous transporter loci enables real-time imaging and proteomic analysis of RNA transport in living cells.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression of RNA transporters enhances RNA uptake, facilitating studies of systemic RNAi and RNA-based therapeutics.
How EDITGENE Supports RNA transmembrane transporter activity Research
Researchers studying RNA transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in RNA uptake, export, or intercellular transfer. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research, from knockout to knock-in models and high-throughput screens.
Contact EDITGENE today to design your custom CRISPR model for RNA transmembrane transporter activity research.
Frequently Asked Questions About RNA transmembrane transporter activity
What is RNA transmembrane transporter activity?
RNA transmembrane transporter activity (GO:0051033) is a molecular function that enables the transfer of RNA across a membrane.
What genes are involved in RNA transmembrane transporter activity?
Key genes include SID-1, SIDT1, SIDT2, and accessory factors such as SID-2 and SID-5.
How does RNA transmembrane transport work?
It involves substrate binding, membrane translocation through a channel, and release into the cytoplasm.
What diseases are associated with RNA transmembrane transporter activity?
Dysregulation is linked to viral infections, cancer, and neurodegenerative disorders.
What is the role of SID-1 in RNA transport?
SID-1 is a primary dsRNA channel that mediates systemic RNAi and cellular RNA uptake.
How can I study RNA transmembrane transporter activity?
Use CRISPR knockout, knock-in, overexpression, and high-throughput screens combined with RNA-seq and imaging [1,2,6].
What are the research methods for RNA transmembrane transport?
Methods include RNA-seq, Ribo-seq, cryo-EM, CRISPR screens, and fluorescence microscopy [4,6].
Can CRISPR be used to study RNA transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression are powerful tools for dissecting RNA transporter function [1,6].
What is the clinical relevance of RNA transmembrane transporters?
They are targets for enhancing RNA drug delivery and for antiviral therapies.
Where can I find CRISPR services for RNA transporter research?
EDITGENE offers comprehensive CRISPR services including knockout, knock-in, overexpression, and library screening [2,6].
Conclusion
RNA transmembrane transporter activity (GO:0051033) is a fundamental molecular function that mediates the movement of RNA across membranes, with critical roles in systemic RNAi, antiviral defense, and intercellular signaling. Dysregulation of this activity contributes to viral infections, cancer, and neurodegenerative diseases. Advances in CRISPR-based models and high-throughput screening are accelerating the discovery of new regulators and therapeutic targets [1,2]. EDITGENE provides end-to-end CRISPR solutions to support researchers in this rapidly evolving field.
References
- 1. Farinha CM et al.. 2022. Molecular mechanisms of cystic fibrosis - how mutations lead to misfunction and guide therapy.. Biosci Rep 42(7) PMID: 35707985
- 2. Shen J et al.. 2022. Membrane-Active Molecular Machines.. Acc Chem Res 55(8):1148-1159 PMID: 35345880
- 4. Nguyen DH et al.. 2024. RNA therapeutics for diarrhea.. Prog Mol Biol Transl Sci 204:295-309 PMID: 38458741
- 6. Hirano Y et al.. 2024. Cryo-EM analysis reveals human SID-1 transmembrane family member 1 dynamics underlying lipid hydrolytic activity.. Commun Biol 7(1):664 PMID: 38811802
